Carmell Total Current Liabilities vs Common Stock Shares Outstanding Analysis
| CTCXW Stock | 0.06 0 1.96% |
Carmell Therapeutics financial indicator trend analysis is way more than just evaluating Carmell Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Carmell Therapeutics is a good investment. Please check the relationship between Carmell Therapeutics Total Current Liabilities and its Common Stock Shares Outstanding accounts. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Total Current Liabilities vs Common Stock Shares Outstanding
Total Current Liabilities vs Common Stock Shares Outstanding Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Carmell Therapeutics Total Current Liabilities account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have pay attention.
The correlation between Carmell Therapeutics' Total Current Liabilities and Common Stock Shares Outstanding is -0.89. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Carmell Therapeutics, assuming nothing else is changed. The correlation between historical values of Carmell Therapeutics' Total Current Liabilities and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Carmell Therapeutics are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Total Current Liabilities i.e., Carmell Therapeutics' Total Current Liabilities and Common Stock Shares Outstanding go up and down completely randomly.
Correlation Coefficient | -0.89 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Total Current Liabilities
Total Current Liabilities is an item on Carmell Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Carmell Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most indicators from Carmell Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Carmell Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. Selling General Administrative is likely to drop to about 2.5 M in 2024. Issuance Of Capital Stock is expected to grow at the current pace this year
| 2010 | 2022 | 2023 | 2024 (projected) | Interest Expense | 2.5M | 3.7M | 889.3K | 844.9K | Depreciation And Amortization | 242.1K | 242.6K | 124.8K | 162.5K |
Carmell Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Carmell Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Carmell Stock Analysis
When running Carmell Therapeutics' price analysis, check to measure Carmell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carmell Therapeutics is operating at the current time. Most of Carmell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Carmell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carmell Therapeutics' price. Additionally, you may evaluate how the addition of Carmell Therapeutics to your portfolios can decrease your overall portfolio volatility.